On June 10, 2025, LENZ Therapeutics, Inc. held their annual meeting where 17,983,676 out of 27,544,520 shares were represented; they elected directors and ratified Ernst & Young LLP as the accounting firm for 2025.
AI Assistant
LENZ THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.